GLOW stack[BPC-157 + TB-500 + GHK-Cu blend]
Compound snapshot
Class
Informal community blend
FDA approved
Research use only — an informal community blend, not an approved medicine
Clinical development
Discovery
Last reviewed
September 2026
Research areas
Community blend / Recovery / Tissue repair
Regulatory status
Research use only — an informal community blend, not an approved medicine
Internet attention
High
Registry query
GLOW stack
The Wolverine pairing plus GHK-Cu, the copper tripeptide used in cosmetic skin research. Marketed toward skin, collagen and wound appearance alongside tissue repair.
Reality check — what we actually know
Supported by human evidence
- This compound has completed human trials in at least one approved indication — see the regulatory section for what was actually approved.
Animal research only
- The repair rationale of the base pair plus a skin and collagen angle
- GHK-Cu has the most consumer-facing evidence of the three, mainly topical cosmetic studies
- Single vial covers three separate described pathways
Mechanistically plausible
- Adds copper-dependent matrix remodelling to the angiogenesis and cell-migration rationale of the base pair. GHK-Cu is studied for collagen and elastin production in skin, and gives a reconstituted blend its characteristic blue tint — that colour is the copper complex, not contamination.
Common internet claims
- Online discussion frequently presents GLOW stack as a proven treatment rather than a research compound.
Not established
- Human efficacy for the outcomes commonly claimed
- Optimal route, quantity and duration in humans
- Long-term human safety
Evidence distribution
Each band is a live PubMed search for GLOW stack, filtered to that kind of study. Top is the strongest evidence; the base is reasoning, not proof. A band with no records means that kind of study has not been published for this compound yet.
Mechanism and reported findings
Adds copper-dependent matrix remodelling to the angiogenesis and cell-migration rationale of the base pair. GHK-Cu is studied for collagen and elastin production in skin, and gives a reconstituted blend its characteristic blue tint — that colour is the copper complex, not contamination.
- The repair rationale of the base pair plus a skin and collagen angle
- GHK-Cu has the most consumer-facing evidence of the three, mainly topical cosmetic studies
- Single vial covers three separate described pathways
Strength of the evidence: No controlled trial has tested GLOW as a fixed combination. GHK-Cu's human data are largely small topical skin studies; injected use in a multi-peptide blend has not been studied.
Safety and known cautions
Copper-containing peptides raise the question of cumulative copper exposure, which nobody has characterised for repeated injected use. Same unapproved, unregulated supply problem as the base pair, with a third variable added.
Evidence at a glance
No single score, on purpose. The line beside each bar shows how much reported outcomes vary between studies.
Development stage
- DiscoveryCurrent
- Preclinical
- Phase 1
- Phase 2
- Phase 3
- Regulatory review
- Approved